BioSig Technologies enters $8.5M ATM offering with H.C. Wainwright

Streamex Corp.

Up to $8.5M of common stock may be sold at-the-market through H.C. Wainwright as agent.
Agent receives 3% commission on gross sales; sales at prevailing market prices.
Net proceeds to be used for working capital and general corporate purposes.
Offering made under shelf registration statement declared effective Dec 17, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.